References
- Yoto Y, Kudoh T, Suzuki N, Matsunaga Y, Chiba S. Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases. Acta Haematol 1993;90: 8–12.
- Marmont MA. Therapy of pure red cell aplasia. Semin Hematol 1991;28:285–97.
- Chitnavis VN, Patou G., Makar YF, Kendra JR. B19 parvovirus induced red cell aplasia complicating acute cold antibody mediated haemolytic anaemia. Br J Haematol 1990;76:433–4.
- Chehal A, Sharara Al, Haidar HA, Haidar J, Bazarbachi A. Acute viral hepatitis A and parvovirus B19 infections complicated by pure red cell aplasia and autoimmune hemolytic anemia. J Hepatol 2002;37: 163–5.
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield 14. NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271–7.
- Evans RS, Takahashi K, Duane RT, Payne R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med 15. 1951;87:48–65.
- Tsukamoto A. A case of immunoblastic lymphadenopathy (IBL) type T cell lymphoma complicated by Evans syndrome and pure red cell aplasia (in Japanese). Ftinsho Ketsueki 1993;34:983.16.
- Oikawa Y A case of Evans syndrome complicated by B19 parvovirus-induced acute pure red cell aplasia (in Japanese). Igaku Kensa 1993;42:375.
- Katori H, Hoshino J, Sawa N, Tagami T, Nyuuhara Y, Takemoto 17. H, et al. A case of membranous proliferative glomerulonephritis (MPGN) type I complicated by parvovirus-induced pure red cell 18. aplasia (in Japanese). Jin'en Syourei Kenkyuukai 2005;21: 120–35.19.
- Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cel- lular receptor for B19 parvovirus. Science 1993;262: 114–7.20.
- Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 21. 1994;330:1192–6.
- Kunimi M, Ishikawa K, Tsutsumi H, Hirai M, Kumakawa T, Mori M. Parvovirus infection and hemolytic anemia. Am J Hematol 1994;46:159–60.
- Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy: a 22. hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975;292:1–8.
- Siegert W, Nerl C, Agthe A, Engelhard M, Brittinger G, Tiemann M, et al. Angioimmunoblastic lymphadenopathy (AILD)-type T cell lymphoma: prognostic impact of clinical observations and lab-oratory findings at presentation. The Kiel Lymphoma Group. Ann Oncol 1995;6:659–64.
- Pierce DA, Stern R, Jaffe R, Zulman J, Talal N. Immunoblastic sarcoma with features of Sjögren's syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy. Arthritis Rheum 1979;22:911–6.
- Lynch JW, Elfenbein GJ, Noyes WD, BrayIan RC, Gross MA, Weiner RS. Pure red cell aplasia associated with angioimmuno-blastic lymphadenopathy with dysproteinemia. Am J Hematol 1994;46:72–8.
- Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis: mixed warm and cold antibody type. Acta Haemat 1983;69:166–74.
- Anderson JR, Goudie RB, Gray KG, Timbury GC. Auto-antibod-ies in Addison's disease. Lancet 1957;272:1123–4.
- Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndrome. Pediatr Ann 1980;9:154–62.
- Neufeld M, Maclaren N, Blizzard R. Two types of autoimmune Addison's disease associated with different polyglandular auto-immune (PGA) syndrome. Medicine 1981;60:355–62.
- Hara T, Mizuno Y, Nagata M, Okabe Y, Taniguchi S, Harada M, et al. Human gamma delta T-cell receptor-positive cell-mediated inhibition of erythropoiesis in vitro in a patient with type II auto-immune polyglandular syndrome and pure red cell aplasia. Blood 1990;75:941–50.
- Grossi A, Nozzoli C, Gheri R, Santini V, Marrani C, Zoccolante A. Pure red cell aplasia in autoimmune polyglandular syndrome with T lymphocytosis. Haematologica 1998;83:1043–5.